Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In

Saint Nikolozi Surgery and Oncological Centre, Kutaisi

Unimed Adjara - Oncology Center, Kutaisi

Research Institute of Clinical Medicine, Tbilisi

Cancer Center of Adjara Autonomous Republic, Batumi

Wake Forest Baptist Medical Center, Winston-Salem

Hope Women's Cancer Centers, Asheville

Orlando Health, Inc., Orlando

Office of Human Research, Hollywood

UAB Comprehensive Cancer Center, Birmingham

Ft. Wayne Hematology and Oncology, Fort Wayne

Ft. Wayne Medical Oncology & Hematology, Inc, Fort Wayne

Frauenshuh Cancer Center at Park Nicollet Health Service, Saint Louis Park

Cancer Center of Kansas, Wichita

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas

Saint Mary's Regional Cancer Center, Grand Junction

Torrance Memorial Cancer Care Associates, Redondo Beach

UCLA Hematology/Oncology - Santa Monica, Santa Monica

Los Angeles Hematology Oncology Medical Group, Glendale

St. Jude Medical Center, Fullerton

CBCC Global Research at Comprehensive Blood and Cancer Center, Bakersfield

SLO Oncology and Hematology Health Center, San Luis Obispo

Central Coast Medical Oncology Group, Santa Maria

Saint Barnabas Medical Cancer Center, Livingston

Health House, Tbilisi

Institute of Clinical Oncology, Tbilisi

New Vision University Hospital, Tbilisi

Cancer Research Center, Tbilisi

S. Khechinashvili, University Hospital, Tbilisi

Multiprofile Clinic Consilium Medulla, Tbilisi